Ex parte QUIMBY, JR. et al. - Page 4




                     Appeal No. 2000-1568                                                                                                                                              
                     Application 08/695,249                                                                                                                                            
                     of preparing a granular biocontrol agent which comprises (i) blending an aqueous                                                                                  
                     suspension of a biocontrol agent selected from the group consisting of bacteria, fungi,                                                                           
                     viruses, microsporidians, protozoa, nematodes and pathogenic components thereof with a                                                                            
                     water absorbent material and a membrane stabilization agent into a dough, (ii) blending                                                                           
                     the dough of subsection (i) with a granulating agent to produce granules, and (iii)                                                                               
                     recovering the granules of subsection (ii).  The granules can be dispersed in water to                                                                            
                     produce a sprayable formulation.                                                                                                                                  
                                According to the specification, the present formulation is useful in the control of                                                                    
                     agricultural pests such as insects, weeds, crop diseases, and detrimental nematodes.                                                                              
                     Specification, p. 5.                                                                                                                                              
                     I.         § 112, second paragraph rejection                                                                                                                      
                                First, the examiner contends that claims 1 and 9 are vague and indefinite in the                                                                       
                     recitation of “and pathogenic components of said agents.” Answer, p. 3.  According to the                                                                         
                     examiner,  it is not clear which parts of the claimed biocontrol agents are pathogenic.  Id.                                                                      
                     We find the examiner’s position untenable.                                                                                                                        
                                A seminal case which provides guidance for determining whether the claims satisfy                                                                      
                     the requirements of the second paragraph of § 112 is In re Moore, 439 F.2d 1232, 169                                                                              
                     USPQ 236 (CCPA 1971).  There, the court pointed out, inter alia, that “the definiteness of                                                                        
                     the language employed must be analyzed- not in a vacuum, but always in light of the                                                                               
                     teachings of the prior art and of the particular application disclosure as it would be                                                                            


                                                                                          4                                                                                            





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007